Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 33 clinical trials
Featured trial
Adult and Adolescent Participants with Inadequately Controlled Asthma

This is a variable length study to evaluate the efficacy and safety of a new triple therapy inhaler (Budesonide/Glycopyrronium/Formoterol) in adults and adolescents with severe asthma

  • 0 views
  • 04 Jan, 2022
  • 1 location
Featured trial
  • 117 views
  • 23 Nov, 2020
  • 1 location
The Efficacy of Budesonide/Formoterol in Cough Variant Asthma

ICS/LABA for 3 months. Overall, the best treatment of CVA is not yet clear. GINA 2018 emphasize that asthma need long-term management. Euro-SMART study found that budesonide/formoterol 2

  • 14 views
  • 24 Jan, 2021
  • 1 location
Incidence of Acute Laryngeal Injury Following Endotracheal Intubation

injury Initiate a randomized control trial to investigate the ability of azithromycin and budesonide to improve objective and subjective breathing measures in patients with Acute Laryngeal

endotracheal intubation
budesonide
  • 138 views
  • 05 Nov, 2021
  • 1 location
Ketotifen for Children With Functional Dyspepsia in Association With Duodenal Eosinophilia (Ketotifen)

mucosal eosinophilia is as follows: acid-reducing medication/montelukast addition of H1 antagonist addition of budesonide addition of oral cromolyn. If ketotifen is effective, it offers the advantage

budesonide
mast cell stabilizers
endoscopy
montelukast
mast cells
  • 14 views
  • 12 Feb, 2022
  • 1 location
Intranasal Retinoic Acid Treatment for Patients With OlfactoryLOSS: A RANDOMIZED CONTROLLED TRIAL

About One to 2 percent of the North American population below the age of 65 years experience olfactory loss to a significant degree. It can result from advanced age, Post-infestious/inflammatory disorders, Obstructive disorders (e.g. nasal polyposis, tumors), posttraumatic (head trauma) and neurodegenerative disorders. Only a few studies have shown benefits …

  • 0 views
  • 04 Mar, 2022
  • 2 locations
Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma

This is a randomized, placebo-controlled and double-blind study to evaluate the efficacy and safety of FB825 in adult patients with moderate-to-severe allergic asthma.

  • 0 views
  • 21 Apr, 2022
  • 4 locations
Efficacy and Safety of On-demand and Continuous Administration of Nasal Spray in the Treatment of Allergic Rhinitis

WHO recommend to divide AR into 4 subgroups according to the symptom frequency (intermittent or persistent) and severity (mild or moderate-to-severe). For the persistent moderate-to-severe AR subgroup, the guideline suggests to treat with intranasal corticosteroid (INS) plus antihistamines (AH1) for 2-4 weeks. If the symptom is controlled then degrade the …

  • 0 views
  • 11 May, 2022
Dupilumab for Prevention of Recurrence of CRSwNP After ESS

The investigators believe that administering Dupilumab during the pre- and peri-operative period of surgery for chronic rhinosinusitis with nasal polyps (CRSwNP) will safely downregulate Type 2 inflammation of the healing sinus environment and will allow for better coordinated and more effective mucosal healing. Specifically, the investigators believe that endoscopic signs …

  • 0 views
  • 13 Jun, 2021
  • 1 location
The Budesonide in Babies (BiB) Trial (BiB)

This is a Phase 3, randomized, masked, active-controlled, multicenter trial designed to determine whether early intratracheal administration of a combination of budesonide with surfactant, as

  • 16 views
  • 25 Apr, 2022
  • 13 locations